참고문헌
- Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 1974;6:98-118. https://doi.org/10.1111/j.1399-0004.1974.tb00638.x
- Patel PI, Lupski JR. Charcot-Marie-Tooth disease: a new paradigm for the mechanism of inherited disease. Trends Genet 1994;10:128-33. https://doi.org/10.1016/0168-9525(94)90214-3
- Berciano J, Sevilla T, Casasnovas C, Sivera R, Vilchez JJ, Infante J, et al. [Guidelines for molecular diagnosis of Charcot-Marie-Tooth disease]. Neurologia 2012;27:169-78. Spanish. https://doi.org/10.1016/j.nrleng.2012.04.006
- Bird TD. Charcot-Marie-Tooth hereditary neuropathy overview. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, eds. GeneReviews®. Seattle (WA): University of Washington, Seattle, 1993-2022.
- Braathen GJ. Genetic epidemiology of Charcot-Marie-Tooth disease. Acta Neurol Scand Suppl 2012;193:iv-22.
- Hoogendijk JE, Hensels GW, Zorn I, Valentijn L, Janssen EA, de Visser M, et al. The duplication in Charcot-Marie-Tooth disease type 1a spans at least 1100 kb on chromosome 17p11.2. Hum Genet 1991;88:215-8. https://doi.org/10.1007/BF00206075
- Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66:219-32. https://doi.org/10.1016/0092-8674(91)90613-4
- Filadi R, Pendin D, Pizzo P. Mitofusin 2: from functions to disease. Cell Death Dis 2018;9:330. https://doi.org/10.1038/s41419-017-0023-6
- Tomaselli PJ, Horga A, Rossor AM, Jaunmuktane Z, Cortese A, Blake JC, et al. IGHMBP2 mutation associated with organ-specific autonomic dysfunction. Neuromuscul Disord 2018;28:1012-5. https://doi.org/10.1016/j.nmd.2018.08.010
- Grace J, El-Toukhy T, Scriven P, Ogilvie C, Pickering S, Lashwood A, et al. Three hundred and thirty cycles of preimplantation genetic diagnosis for serious genetic disease: clinical considerations affecting outcome. BJOG 2006;113:1393-401. https://doi.org/10.1111/j.1471-0528.2006.01143.x
- Wang CW, Liu YL, Chen CH. Targeting myotonic dystrophy by preimplantation genetic diagnosis-karyomapping. Taiwan J Obstet Gynecol 2019;58:891-4. https://doi.org/10.1016/j.tjog.2019.04.002
- Handyside AH, Harton GL, Mariani B, Thornhill AR, Affara N, Shaw MA, et al. Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet 2010;47:651-8. https://doi.org/10.1136/jmg.2009.069971
- Natesan SA, Bladon AJ, Coskun S, Qubbaj W, Prates R, Munne S, et al. Genome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in vitro. Genet Med 2014;16:838-45. https://doi.org/10.1038/gim.2014.45
- Gimenez C, Sarasa J, Arjona C, Vilamajo E, Martinez-Pasarell O, Wheeler K, et al. Karyomapping allows preimplantation genetic diagnosis of a de-novo deletion undetectable using conventional PGD technology. Reprod Biomed Online 2015;31:770-5. https://doi.org/10.1016/j.rbmo.2015.08.017
- Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril 2000;73:1155-8. https://doi.org/10.1016/S0015-0282(00)00518-5
- Ben-Nagi J, Wells D, Doye K, Loutradi K, Exeter H, Drew E, et al. Karyomapping: a single centre's experience from application of methodology to ongoing pregnancy and live-birth rates. Reprod Biomed Online 2017;35:264-71. https://doi.org/10.1016/j.rbmo.2017.06.004
- Forman EJ, Tao X, Ferry KM, Taylor D, Treff NR, Scott RT Jr. Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage rates. Hum Reprod 2012;27:1217-22. https://doi.org/10.1093/humrep/des020
- Wells D, Delhanty JD. Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization. Mol Hum Reprod 2000;6:1055-62. https://doi.org/10.1093/molehr/6.11.1055